Mutations in the tyrosine kinase domain of the HER2 gene which were similar to those described for the EGFR gene were detected at very low frequencies in NSCLC and are probably not clinically relevant [37,38]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.